A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1

Prostate cancer (PCa) is one of the leading causes of cancer-related deaths in men. Localised PCa can be treated effectively, but most patients relapse/progress to more aggressive disease. One possible mechanism underlying this progression is alternative splicing of the androgen receptor, with AR va...

Full description

Bibliographic Details
Published in:	Translational Oncology
Main Authors:	K.M. Biernacka, R. Barker, A. Sewell, A. Bahl, C.M. Perks
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Subjects:	ARV7 Androgen receptor FOXA1 IGFBP-2 Chemotherapy Prostate cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523323000840

Similar Items

Immunohistochemical expression of FOXA1 and Androgen receptor in breast carcinoma in Upper Egypt
by: Seham Abdelrazik Ismail Ismail, et al.
Published: (2024-07-01)

Detection of Androgen Receptor Variant 7 (<i>ARV7)</i> mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
by: Claudia Hille, et al.
Published: (2019-09-01)

Comparing the Expression of Foxa1 and Foxa2 Genes in the Stomach in Men and Women
by: Zahra Mohammadi, et al.
Published: (2015-11-01)

HIF1α-PHD1-FOXA1 Axis Orchestrates Hypoxic Reprogramming and Androgen Signaling Suppression in Prostate Cancer
by: Limiao Liang, et al.
Published: (2025-07-01)

Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer cells
by: Atsuhiko Yoshizawa, et al.
Published: (2021-03-01)

Pioneer of prostate cancer: past, present and the future of FOXA1
by: Mona Teng, et al.
Published: (2020-09-01)

ARv7 promotes the escape of prostate cancer cells from androgen deprivation therapy-induced senescence by mediating the SKP2/p27 axis
by: Dian Zhuang, et al.
Published: (2025-02-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
by: Sherly I. Celada, et al.
Published: (2023-10-01)

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma
by: Jinhui Liu, et al.
Published: (2022-07-01)

FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer
by: Soledad A Camolotto, et al.
Published: (2018-11-01)

Immunohistochemical study of FoxA1 in Invasive Duct Carcinoma of the Breast and Corresponding Lymph Node Metastasis
by: Wafaa Aref, et al.
Published: (2020-10-01)

Effects of Silymarin on Blood Glucose Concentration, Hepatic Histopathological Changes and FOXA2 and FOXA3 Gene Expression in Streptozotocin-Induced Diabetic Male Wistar Rats
by: Sajad Nikkhah, et al.
Published: (2021-12-01)

The Role of FOXA1 in Human Normal Development and Its Functions in Sex Hormone-Related Cancers
by: Juan Zhu, et al.
Published: (2024-06-01)

Intrinsic, pro-apoptotic effects of IGFBP-3 on breast cancer cells are reversible: Involvement of PKA, Rho and ceramide.
by: Claire M Perks, et al.
Published: (2011-05-01)

Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2
by: Yahong Xu, et al.
Published: (2023-09-01)

Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients
by: Ruan W, et al.
Published: (2017-06-01)

Endometrial expression of FOX proteins (FOXA1 and FOXA2) in women of reproductive age with different endometrial thickness: prospective cohort comparative study
by: Natalia V. Aganezova, et al.
Published: (2023-10-01)

IGFBP2 and IGFBP4 interact to activate complement pathway in diabetic kidney disease
by: Jieling Liang, et al.
Published: (2025-12-01)

IGFBP7 promotes gastric cancer by facilitating epithelial-mesenchymal transition of gastric cells
by: Jinqing Wang, et al.
Published: (2024-05-01)

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants
by: Violet A. Daniels, et al.
Published: (2024-01-01)

Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study
by: Anna Szyszkowska, et al.
Published: (2022-05-01)

IGFBP7 mediates oxLDL-induced human vascular endothelial cell injury by suppressing the expression of SIRT1
by: Jiaju Sun, et al.
Published: (2024-08-01)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
by: Meng Zhou, et al.
Published: (2023-08-01)

NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers
by: Juan Guzman, et al.
Published: (2024-03-01)

Effects of Insufficient Levels of Dietary Protein on IGF-I and IGFBPs in Young Chickens
by: Kenji Nagao, et al.
Published: (2010-07-01)

IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
by: Qing Cai, et al.
Published: (2020-05-01)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
by: Namrata Khurana, et al.
Published: (2020-01-01)

FOXA1 expression in Iraqi women with ER+ breast cancer
by: Iman Al-Bedairy, et al.
Published: (2020-06-01)

Sheep IGFBP2 and IGFBP4 promoter methylation regulates gene expression and hair follicle development
by: Yuezhen Tian, et al.
Published: (2022-09-01)

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
by: Haiwei Wang, et al.
Published: (2023-02-01)

Genetic variability in <it>IGF-1</it> and <it>IGFBP-3</it> and body size in early life
by: Poole Elizabeth M, et al.
Published: (2012-08-01)

Effect of hypoxia on the expression of genes that encode some IGFBP and CCN proteins in U87 glioma cells depends on IRE1 signaling
by: O. H. Minchenko, et al.
Published: (2015-12-01)

Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis
by: Wenn-Chyau Lee, et al.
Published: (2020-02-01)

FOXA2 in cancer: from fundamental biology to clinical translation
by: Yongran Xia, et al.
Published: (2026-05-01)

Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells
by: Ko Igarashi, et al.
Published: (2020-08-01)

IGFBP7 is a predictor of diuretic-induced acute kidney injury in the patients with acute decompensated heart failure
by: Görgülü Sinan, et al.
Published: (2022-08-01)

An Integrated Transcriptome Analysis Reveals IGFBP7 Upregulation in Vasculature in Traumatic Brain Injury
by: Jianhao Wang, et al.
Published: (2021-01-01)

Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01)

The role of 11-oxygenated androgens in prostate cancer
by: Gido Snaterse, et al.
Published: (2023-04-01)